İdiopatik Trombositopenik Purpuralı Bir Olguda Eltrombopag Kullanımı ile İlişkili İskemik İnme

Idiopatik trombositopenik purpura (ITP) tedavisinde kul- lanılmakta olan eltrombopag gibi trombopoetin reseptör (TpoR) agonistlerinin iskemik serebrovasküler hastalık oluşturma riski nadir görülmektedir. 5 yıldır ITP tanısı ile takip edilen sağ hemiparezi ve afazi kliniği ile acil servi- se başvuran hastaya yapılan tetkikler sonucunda iskemik serebrovasküler hastalık tanısı konuldu. Olguda serebro- vasküler hastalığın etyolojisi eltrombopag ile ilişkilendiril- di. Bu olgunun nadir görülmesi nedeniyle literatür eşliğin- de tartışıldı.

An Ischemic Stroke Related to Eltrombopag Use in a Patient with Idiopathic Thrombocytopenic Purpura

Thrombopoetin receptor agonists like eltrombopag, used for Idiopathic Thrombocytopenic Purpura treatment rarely cause to the ischemic cerebrovascular disease. In this re- port, a patient, have been followed by ITP diagnosis for 5 years, admitted to the emergency service for right hemi- paresis and aphasia. It was diagnosed as ischemic cere- brovascular disease. Etiology of patient’s cerebrovascu- lar event was associated with eltrombopag. Because of this rare seen situation, it was argued by in the light of the literature.

___

  • 1. Chen YC, Wu JS, Yang ST, et al. Stroke, angiogenesis and phytochemicals. Front Biosci 2012; 4:599-610. 2. Bussel JB, Cheng G, Saleh MN, et al: Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. New Engl J Med 2007; 357:2237-2247. 3. Park HK, Lee SH. Ischemic stroke associated with immune thrombocytopenia: lesion patterns and characteristics. Neu- rol Sci 2014; 35:1801-1806 4. Sarpatwari A, Bennett D, Logie JW, et al. Thromboembolic events among adult patients with primary immune throm- bocytopenia in the United Kingdom General Practice Re- search Database. Haematologica 2010; 95:1167-1175. 5. Aoki T, Harada Y, Matsubara E, et al. Thrombopoietin recep- tor agonists in refractory immune thrombocytopenia: dif- ferential responses to eltrombopag and romiplostim: a case report and possible explanations. J Clin Pharm Theraps 2012; 37:729-732. 6. Norgaard M: Thrombosis in patients with primary chronic immune thrombocytopenia. Thrombosis research. 2012; 130:74-75. 7. Jenkins JM, Williams D, Deng Y, et al. Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin recep- tor agonist. Blood 2007; 109:4739-4741. 8. Catala-Lopez F, Corrales I, Martin-Serrano G, et al. Risk of thromboembolism with thrombopoietin receptor agonists in adult patients with thrombocytopenia: systematic review and meta-analysis of randomized controlled trials. Med Clin 2012; 139:421-429. 9. Haselboeck J, Kaider A, Pabinger I, Panzer S. Function of eltrombopag-induced platelets compared to platelets from control patients with immune thrombocytopenia. Thromb Haemost 2013; 109:676-683. 10. Andic N, Gunduz E, Akay OM, et al. Cardiac and pulmo- nary thrombosis during multidrug treatment in an idio- pathic thrombocytopenic purpura patient. Platelets 2014; 25:69-70 11. Cheng G, Saleh MN, Marcher C, et al. Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study. Lancet 2011; 377:393-402. 12. Tomiyama Y, Miyakawa Y, Okamoto S, et al: A lower start- ing dose of eltrombopag is efficacious in Japanese patients with previously treated chronic immune thrombocytopenia. J Thromb Haemost 2012; 10:799-806.
Dicle Tıp Dergisi-Cover
  • ISSN: 1300-2945
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 1963
  • Yayıncı: Cahfer GÜLOĞLU
Sayıdaki Diğer Makaleler

Künt Dalak Yaralanmalarında Cerrahi Tedavi ile Nonoperatif Yaklaşımın Klinik Sonuçlarının Karşılaştırılması

ZÜLFÜ BAYHAN, SEZGİN ZEREN, Mehmet Fatih EKİCİ, Cüneyt KAHRAMAN, Turgut ŞİMŞEK

Frequency of Stent Placement after Ureteroscopic Lithotripsy in a University and a State Hospital

HÜSEYİN ÇELİK, AHMET ÇAMTOSUN, Caner Ediz, İbrahim TOPÇU, RAMAZAN ALTINTAŞ, Cemal TAŞDEMİR

Effects of Intragastric Balloon on Body Mass Index, Lipid Profile and Blood Glucose Regulation: A Prospective Study

Hasan ERDEM, Süleyman ÇETİNKÜNAR, Mehmet AZİRET, Recep AKTİMUR, Sabri ÖZDAŞ, Fahri TETİŞİR, Banu YÜREKLİ

The Effects of Short-Term Intensive Exercise on Levels of Liver Enzymes and Serum Lipids in Kick Boxing Athletes

Ömer KAYNAR, Nurinnisa ÖZTÜRK, Fatih Kıyıcı, Nurcan BAYGUTALP, Ebubekir Bakan

Epidemiology and Endoscopic Findings of the Patients Suffering from Upper Gastrointestinal System Bleeding

Mehmet YALÇIN, Banu KARA, Nevin A ÖZTÜRK, Şehmus ÖLMEZ, Burçak E. TAŞDOĞAN, Adnan TAŞ

Ureteroscopy and Laser Lithotripsy for Treatment of Ureteral Stones in Pregnants: Single Center Experience

Mustafa İstanbulluoğlu, Hüsnü Alptekin2, Hatice Işık2, İbrahim Buldu

The Effect of Maternal Hypothyroidism on Fetal Umbilical Cord Brain-Derived Neurotrophic Factor Levels

Hüsnü ALPTEKİN, Nazife ALPTEKİN, Hatice IŞIK, Yusuf TANRIKULU, Emel ŞAHİN

Determination of P-Glycoprotein Expression by Flow Cytometry in Hematological Malignancies

BERKAY SARAYMEN, AYSUN ÇETİN, Behzat ÇİMEN, İHSAN ÇETİN, MUSTAFA YAVUZ KÖKER, Bülent ESER

Hematolojik Malignansilerde P-Glikoprotein Ekspresyonunun Akım Sitometri İle Belirlenmesi

Berkay Saraymen, Behzat Çimen, İhsan Çetin, Mustafa Köker, Aysun Çetin, Bülent Eser

Chest Pain may be the First Symptom of Malignant Tumors in Children: Report of Two Cases

Alper Akın, Meki Bilici, Murat Söker, Bedri Aldudak, Fatih Meteroğlu